BM HLA-A2 tumor epitope–specific CD8⁺ T cells activated in vitro by BM DCs through crosspresentation. Representative plots and percentages (from 4 MM patients) of pentamer-binding populations upon stimulation with DCs loaded with tumor antigen in the absence (top) and presence of a CD91-blocking mAb (bottom).